This article was originally published in The Gray Sheet
Automated blood screening system is used with antigen/antibody-based tests for hepatitis and HIV but not with nucleic acid tests (NAT), as was reported in "The Gray Sheet" (June 25, 2001, p. 12). The system is unrelated to Chiron's NAT products, including the Procleix HCV and HIV NAT system under development in cooperation with Gen-Probe
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.